2019年度影响力**的20篇医学论文

2019-12-30 MedSci梅斯 MedSci梅斯

近日,Altmetric网站公布了2019年度“Altmetric百篇论文”,Altmetric是一家跟踪和分析与学术文献有关的在线活动的公司。 “Altmetric百篇论文”是由该公司收集的,年度影响力最高的100篇论文合集,这些论文的共同特点是具有高度的社会影响力,能够引起公众的广泛讨论。 下面让我们来看看其中生物医药领域研究的前二十名吧,梅斯医学网站报道了其中的19篇。常读梅斯医

近日,Altmetric网站公布了2019年度“Altmetric百篇论文”,Altmetric是一家跟踪和分析与学术文献有关的在线活动的公司。


“Altmetric百篇论文”是由该公司收集的,年度影响力最高的100篇论文合集,这些论文的共同特点是具有高度的社会影响力,能够引起公众的广泛讨论。

下面让我们来看看其中生物医药领域研究的前二十名吧,梅斯医学网站报道了其中的19篇。常读梅斯医学,世界前沿尽享其中!

1.麻疹&腮腺炎&风疹疫苗(MMR疫苗)接种和自闭症发生之间的关系(Altmetric指数:9199,排名3/100)

论文标题:Measles, Mumps, Rubella Vaccination and Autism
发表期刊:Annals of Internal Medicine
简介:MMR疫苗不会引起自闭症。丹麦研究人员研究了超过65万名儿童的记录,发现接种了MMR疫苗的孩子实际上被诊断出患有自闭症的可能性更低。

2.全球范围内饮食习惯对健康的影响(Altmetric指数:5795,排名11/100)

论文标题:Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
发表期刊:The Lancet
简介:通过追踪数百万人的死亡数据,科学家发现了最大的饮食风险因素。如果想长寿健康,那么应该少吃盐,同时多吃全谷物和水果。
详细报道:Lancet:民以食为天!关于“吃”的风险报告出炉 


3.死亡数小时后大脑循环与细胞功能竟然神奇恢复!(Altmetric指数:4467,排名15/100)
论文标题:Restoration of brain circulation and cellular functions hours post-mortem
发表期刊:Nature
简介:科学家在实验中发现:猪死后四个小时脑组织重新恢复的生命活动,这使人们开始质疑此前对脑死亡的了解。

4.EAT-柳叶刀委员会关于可持续食物系统中健康饮食的研究(Altmetric指数:4301,排名18/100)
论文标题:Food in the Anthropocene: the EAT–Lancet Commission on healthy diets from sustainable food systems
发表期刊:The Lancet
简介:为了保护环境,保持健康同时提供能够维持100亿人口的饮食系统,我们需要将目前的坚果、水果、蔬菜和豆类摄入量加倍,并将肉和糖类摄入量减半。(但是,如果只有40%的人负担得起的话,我们又将何去何从?)

详细报道:Lancet:全球16亿人吃不起这种健康饮食

5.患者的不幸帮助我们了解肺部的结构(Altmetric指数:4298,排名19/100)
论文标题:Disease reveals the beauty of biology: A 20cm-long blood clot that killed a man was molded into the shape of the bronchial tree in his lung.
发表期刊:New England Journal of Medicine
简介:疾病揭示了生物学的美——通过解剖一名因存在20厘米长的血块而死亡的患者,我们获得了对肺部的支气管树状结构的进一步了解。

详细报道:NEJM:右支气管树-病例报道

6.电子烟与尼古丁替代疗法,哪一种更好?(Altmetric指数:4277,排名20/100)
论文标题:A Randomized Trial of E-Cigarettes versus Nicotine-Replacement Therapy
发表期刊:New England Journal of Medicine
简介:想戒烟吗?选择电子烟代替尼古丁贴片,更有可能获得成功呦(前提是得到了大家的支持)。

详细报道:NEJM:电子烟戒烟效果优于尼古丁替代疗法

7.喝饮料与死亡之间的关系(Altmetric指数:4122,排名21/100)
论文标题:Association Between Soft Drink Consumption and Mortality in 10 European Countries
发表期刊:JAMA Internal Medicine
简介:甜甜的饮料会带来苦涩的后果——这项研究表明,喝苏打水的人早死的风险更高,其中与循环系统疾病导致的死亡有关。

详细报道:JAMA Intern Med:十国数据揭示软饮与死亡率之间的关系

8.吃鸡蛋与心血管疾病死亡率之间的关系(Altmetric指数:3913,排名23/100)
论文标题:Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality
发表期刊:JAMA:Journal of the American Medical Association
简介:每天仅仅吃一个鸡蛋可能都会导致心脏病。一项针对30,000人的长达三十年的研究表明,每周仅吃三个或四个鸡蛋,会使患心脏病的风险增加6%,而早死的风险则增加8%。

详细报道:JAMA:日常胆固醇以及鸡蛋摄入与心血管事件风险

9.红肉和加工类肉制品我们吃多少合适?(Altmetric指数:3842,排名25/100)
论文标题:Unprocessed Red Meat and Processed Meat Consumption: Dietary Guideline Recommendations From the Nutritional Recommendations (NutriRECS) Consortium
发表期刊:Annals of Internal Medicine
简介:营养建议协会(NutriRECS)的科学家说,大规模的人群统计结果揭示了食用红色和加工肉的健康风险,但是证据不足以使我们改变饮食习惯。

详细报道:吃红肉不致癌?!权威期刊连发6文拯救红肉爱好者

10.俯卧撑与心血管疾病之间的关系(Altmetric指数:3784,排名26/100)
论文标题:Association Between Push-up Exercise Capacity and Future Cardiovascular Events Among Active Adult Men
发表期刊:JAMA Network Open
简介:想知道心脏有多健康吗,先来40个俯卧撑吧!根据这项为期10年的研究,可以进行40次俯卧撑的中年人患心脏病的风险要比只能完成10次或更少次数的人低。

详细报道:JAMA Netw Open:俯卧撑你能做几个?哈佛科学家发现,半分钟能做40个俯卧撑的人,比做不了10个的人,10年内心血管风险降低96%

11.摄入加工类食品会导致体重增加(Altmetric指数:3578,排名29/100)
论文标题:Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake
发表期刊:Cell Metabolism
简介:如果你您想保持苗条,那就放下汉堡——这项随机对照试验显示,摄入高加工食品的人比摄入未加工食品摄入的卡路里多500,体重也会有明显增加。

详细报道:Cell Metab: 精加工食品导致暴饮暴食和体重增加 

12.含糖饮料与患癌风险(Altmetric指数:3557,排名30/100)
论文标题:Sugary drink consumption and risk of cancer: results from NutriNet-Santé prospective cohort
发表期刊:British Medical Journal
简介:根据这项针对10万人的研究,喝含糖苏打水和果汁会增加患癌症的风险。每天仅多摄入100毫升,就使患乳腺癌的风险增加22%,使整体患癌症的风险增加18%。

详细报道:BMJ:含糖饮料增加肿瘤风险,100%纯果汁也不例外

13.艾滋病患者是否能够安全进行性行为?(Altmetric指数:3493,排名31/100)
论文标题:Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
发表期刊:The Lancet
简介:这项研究发现,正在服用可保持低病毒载量的药物的男同性恋HIV阳性患者即使不使用安全套也不会将HIV传播给未感染的伴侣。

详细报道:Lancet:抗逆转录病毒治疗对同性恋人群HIV的预防效果研究

14.摄入碳水化合物质量与身体健康的关系(Altmetric指数:3444,排名32/100)
论文标题:Carbohydrate quality and human health: a series of systematic reviews and meta-analyses
发表期刊:The Lancet
简介:对覆盖1.35亿人数据的分析表明,食用膳食纤维对健康有影响。对于吃全谷类食品的人来说是个好消息——高纤维饮食伴随着心脏病,某些癌症,糖尿病,超重和高血压的风险降低。

详细报道:LANCET:碳水化合物质量与人类健康关系如何? 

15.麻疹病毒感染对其它类型感染的影响(Altmetric指数:3217,排名35/100)
论文标题:Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens
发表期刊:Science
简介:麻疹的复发比我们想象的要危险得多。这种疾病不仅导致疾病和死亡,而且还“抹去”了人们免疫系统的记忆,使他们容易受到其它类型病原体的感染。

详细报道:Science:麻疹病毒使免疫系统“失忆”?系紧疫苗预防“安全带”

16.细菌与阿兹海默症的关系(Altmetric指数:3216,排名36/100)
论文标题:Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors
发表期刊:Science Advances
简介:尽管尚处于初期阶段,但动物模型显示牙龈疾病与阿尔茨海默氏病的发生与发展之间存在联系,并为预防和治疗阿尔兹海默症提供了潜在的目标。

详细报道:Sci Adv:牙周炎细菌导致阿尔茨海默病实锤!科学家发现导致牙周炎的细菌能轻易侵入大脑,分泌有害蛋白诱发AD

17.每周花两小时感受大自然有助于身体健康(Altmetric指数:3160,排名38/100)
论文标题:Spending at least 120 minutes a week in nature is associated with good health and wellbeing
发表期刊:Scientific Reports
简介:一周仅需2个小时,回归大自然可以使你更健康。在自然环境中(例如公园,林地或海滩)至少停留2个小时后,人们更有可能表现出良好的健康或幸福感,而每周约4个小时的外出会使得健康效果最高。
详细报道:Sci Rep:亲近大自然与良好的身心健康相关

18.HPV疫苗接种对预防宫颈疾病的效果(Altmetric指数:3110,排名42/100)
论文标题:Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
发表期刊:British Medical Journal
简介:我们知道HPV疫苗是有效的,但是这项研究表明,它的好处不仅限于保护个人免受HPV感染和子宫颈癌的侵害,而且还降低了相关的疾病的发生率。
详细报道:BMJ:HPV疫苗接种后宫颈疾病患病率分析

19.不孕患者接受子宫移植后的成功分娩(Altmetric指数:3102,排名43/100)
论文标题:Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility
发表期刊:The Lancet
简介:从死去的供体成功移植子宫后,第一个“奇迹宝宝”诞生了,这给患有不孕症的妇女带来了希望。

详细报道:Lancet:全球首例已故供体子宫移植活产案例 

20.早餐对个人体重的影响(Altmetric指数:2962,排名50/100)
论文标题:Effect of breakfast on weight and energy intake: systematic review and meta-analysis of randomised controlled trials
发表期刊:British Medical Journal
简介:间歇性禁食真的是减肥的关键吗?这项对先前研究的荟萃分析表明,如果想减肥的话,不吃早餐可能是个不错的选择,而吃早餐可能会产生相反的效果。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1947128, encodeId=fbf9194e12809, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Apr 30 05:47:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377825, encodeId=3b403e7825f0, content=学习了,期望更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Sun Jan 05 18:01:04 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377684, encodeId=7eaa3e7684b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b795161273, createdName=146b8d6am69暂无昵称, createdTime=Thu Jan 02 01:16:04 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622975, encodeId=a68f16229e538, content=<a href='/topic/show?id=babb34250ab' target=_blank style='color:#2F92EE;'>#医学论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34250, encryptionId=babb34250ab, topicName=医学论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Dec 31 23:47:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377622, encodeId=1d1d3e76226c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Tue Dec 31 07:42:50 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377620, encodeId=18e23e7620a2, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Dec 31 07:37:41 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377613, encodeId=0cca3e76132d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Tue Dec 31 06:43:56 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377588, encodeId=654b3e7588bd, content=好研究与每个人息息相关, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Dec 30 11:31:06 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1947128, encodeId=fbf9194e12809, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Apr 30 05:47:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377825, encodeId=3b403e7825f0, content=学习了,期望更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Sun Jan 05 18:01:04 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377684, encodeId=7eaa3e7684b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b795161273, createdName=146b8d6am69暂无昵称, createdTime=Thu Jan 02 01:16:04 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622975, encodeId=a68f16229e538, content=<a href='/topic/show?id=babb34250ab' target=_blank style='color:#2F92EE;'>#医学论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34250, encryptionId=babb34250ab, topicName=医学论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Dec 31 23:47:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377622, encodeId=1d1d3e76226c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Tue Dec 31 07:42:50 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377620, encodeId=18e23e7620a2, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Dec 31 07:37:41 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377613, encodeId=0cca3e76132d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Tue Dec 31 06:43:56 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377588, encodeId=654b3e7588bd, content=好研究与每个人息息相关, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Dec 30 11:31:06 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
    2020-01-05 明崖

    学习了,期望更多研究

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1947128, encodeId=fbf9194e12809, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Apr 30 05:47:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377825, encodeId=3b403e7825f0, content=学习了,期望更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Sun Jan 05 18:01:04 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377684, encodeId=7eaa3e7684b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b795161273, createdName=146b8d6am69暂无昵称, createdTime=Thu Jan 02 01:16:04 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622975, encodeId=a68f16229e538, content=<a href='/topic/show?id=babb34250ab' target=_blank style='color:#2F92EE;'>#医学论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34250, encryptionId=babb34250ab, topicName=医学论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Dec 31 23:47:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377622, encodeId=1d1d3e76226c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Tue Dec 31 07:42:50 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377620, encodeId=18e23e7620a2, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Dec 31 07:37:41 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377613, encodeId=0cca3e76132d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Tue Dec 31 06:43:56 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377588, encodeId=654b3e7588bd, content=好研究与每个人息息相关, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Dec 30 11:31:06 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
    2020-01-02 146b8d6am69暂无昵称

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1947128, encodeId=fbf9194e12809, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Apr 30 05:47:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377825, encodeId=3b403e7825f0, content=学习了,期望更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Sun Jan 05 18:01:04 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377684, encodeId=7eaa3e7684b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b795161273, createdName=146b8d6am69暂无昵称, createdTime=Thu Jan 02 01:16:04 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622975, encodeId=a68f16229e538, content=<a href='/topic/show?id=babb34250ab' target=_blank style='color:#2F92EE;'>#医学论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34250, encryptionId=babb34250ab, topicName=医学论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Dec 31 23:47:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377622, encodeId=1d1d3e76226c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Tue Dec 31 07:42:50 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377620, encodeId=18e23e7620a2, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Dec 31 07:37:41 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377613, encodeId=0cca3e76132d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Tue Dec 31 06:43:56 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377588, encodeId=654b3e7588bd, content=好研究与每个人息息相关, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Dec 30 11:31:06 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1947128, encodeId=fbf9194e12809, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Apr 30 05:47:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377825, encodeId=3b403e7825f0, content=学习了,期望更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Sun Jan 05 18:01:04 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377684, encodeId=7eaa3e7684b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b795161273, createdName=146b8d6am69暂无昵称, createdTime=Thu Jan 02 01:16:04 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622975, encodeId=a68f16229e538, content=<a href='/topic/show?id=babb34250ab' target=_blank style='color:#2F92EE;'>#医学论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34250, encryptionId=babb34250ab, topicName=医学论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Dec 31 23:47:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377622, encodeId=1d1d3e76226c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Tue Dec 31 07:42:50 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377620, encodeId=18e23e7620a2, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Dec 31 07:37:41 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377613, encodeId=0cca3e76132d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Tue Dec 31 06:43:56 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377588, encodeId=654b3e7588bd, content=好研究与每个人息息相关, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Dec 30 11:31:06 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
    2019-12-31 Dr Z

    学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1947128, encodeId=fbf9194e12809, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Apr 30 05:47:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377825, encodeId=3b403e7825f0, content=学习了,期望更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Sun Jan 05 18:01:04 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377684, encodeId=7eaa3e7684b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b795161273, createdName=146b8d6am69暂无昵称, createdTime=Thu Jan 02 01:16:04 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622975, encodeId=a68f16229e538, content=<a href='/topic/show?id=babb34250ab' target=_blank style='color:#2F92EE;'>#医学论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34250, encryptionId=babb34250ab, topicName=医学论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Dec 31 23:47:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377622, encodeId=1d1d3e76226c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Tue Dec 31 07:42:50 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377620, encodeId=18e23e7620a2, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Dec 31 07:37:41 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377613, encodeId=0cca3e76132d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Tue Dec 31 06:43:56 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377588, encodeId=654b3e7588bd, content=好研究与每个人息息相关, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Dec 30 11:31:06 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
    2019-12-31 yjs木玉

    好好好好好好

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1947128, encodeId=fbf9194e12809, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Apr 30 05:47:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377825, encodeId=3b403e7825f0, content=学习了,期望更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Sun Jan 05 18:01:04 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377684, encodeId=7eaa3e7684b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b795161273, createdName=146b8d6am69暂无昵称, createdTime=Thu Jan 02 01:16:04 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622975, encodeId=a68f16229e538, content=<a href='/topic/show?id=babb34250ab' target=_blank style='color:#2F92EE;'>#医学论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34250, encryptionId=babb34250ab, topicName=医学论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Dec 31 23:47:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377622, encodeId=1d1d3e76226c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Tue Dec 31 07:42:50 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377620, encodeId=18e23e7620a2, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Dec 31 07:37:41 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377613, encodeId=0cca3e76132d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Tue Dec 31 06:43:56 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377588, encodeId=654b3e7588bd, content=好研究与每个人息息相关, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Dec 30 11:31:06 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1947128, encodeId=fbf9194e12809, content=<a href='/topic/show?id=2ac250319fe' target=_blank style='color:#2F92EE;'>#影响力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50319, encryptionId=2ac250319fe, topicName=影响力)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/L2dMhrxjvSWuPWKZZP1I83Rw21EWia7LVTYJibLQkb4oTibrYLwhnAXntTBWR3FruIzKfNMiaBwhYV0AKNmiaNxfialg/132, createdBy=6ea92500119, createdName=ms9608593228839890, createdTime=Thu Apr 30 05:47:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377825, encodeId=3b403e7825f0, content=学习了,期望更多研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Sun Jan 05 18:01:04 CST 2020, time=2020-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377684, encodeId=7eaa3e7684b1, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b795161273, createdName=146b8d6am69暂无昵称, createdTime=Thu Jan 02 01:16:04 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1622975, encodeId=a68f16229e538, content=<a href='/topic/show?id=babb34250ab' target=_blank style='color:#2F92EE;'>#医学论文#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34250, encryptionId=babb34250ab, topicName=医学论文)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Tue Dec 31 23:47:00 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377622, encodeId=1d1d3e76226c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/08/03/0e492dda8bcc1f98474b74c2863aca87.jpg, createdBy=068d2446376, createdName=Dr Z, createdTime=Tue Dec 31 07:42:50 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377620, encodeId=18e23e7620a2, content=好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Tue Dec 31 07:37:41 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377613, encodeId=0cca3e76132d, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Tue Dec 31 06:43:56 CST 2019, time=2019-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=377588, encodeId=654b3e7588bd, content=好研究与每个人息息相关, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4a5105539, createdName=lovetcm, createdTime=Mon Dec 30 11:31:06 CST 2019, time=2019-12-30, status=1, ipAttribution=)]
    2019-12-30 lovetcm

    好研究与每个人息息相关

    0

相关资讯

年终盘点:2019年JAMA杂志重磅研究

小M汇总了2019年JAMA发表的重磅研究,一起来看吧!

年终盘点:2019趣味研究大盘点,看大佬们如何“玩转科研”!

2019年马上就要过去了,在最近的一年中涌现出了许多振奋人心的科学进展,也有很多有意思的研究能让我们眼前一亮。本文简要罗列了其中一些好玩的故事,让我们看看大佬们都是如何“玩科研”的吧!

年终盘点:2019年BMJ杂志重磅研究

《British Medical Journal》作为顶级医学期刊,其2018年度影响因子增长至27.604,相信2019年的BMJ表现更加给力。那么,在2019年即将结束之时,让我们一起回顾一下本年度BMJ杂志上刊登的精彩研究吧!

年终盘点:2019年Lancet杂志重磅研究

2019年已经进入最后一个月,顶级学术期刊《柳叶刀》在不平凡的2019年里刊登了大量有价值的研究,让我们一起回顾一下吧!

吴一龙教授:2019肺癌大事件盘点

内容概览: 一、一线靶向治疗那些事儿 二、一线免疫治疗那些事儿 三、脑转移治疗的新认识 四、可能影响未来的新发现 -NGS的影响 -老靶点新药物和新靶点新药物 -新的化疗药物 -老事物新认识 2019获得NMPA批准用于肺癌的药物有5个,共7个适应症。 一、2019年,一线靶向治疗那些事儿 FLAURA研究和

2019年生物医药领域国内外重量级奖项盘点

2019年已接近尾声,梅斯对本年度生物医药领域国内外重量级奖项进行盘点,希望读者朋友们能够喜欢。